N/A N=331 Improving Care for Children With Complex Needs
Medically Complex Children · Care Coordination · Case Manager
Primary: Cost of Care — 71692; 70618; 37,677; 56702 US Dollars
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=44 Cirrhosis Medical Home
Cirrhosis, Liver
Primary: Enrollment Rate — 20; 20 Participants
Phase 3 N=377 Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I)
Non Cystic Fibrosis Bronchiectasis
Primary: Mean Annual Non-cystic Fibrosis Bronchiectasis (NCFB) Pulmonary Exacerbation Rate — 0.580; 0.948 number of Pulmonary Exacerbations — p=0.00101
Phase 3 N=1,041 Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)
Asthma · Lung Diseases
Primary: Pulmonary Function as Measured by Normalized FEV1 Over a 4-6 Year Period — 0.6; -0.5; -0.1 percentage of predicted value
Phase 3 N=452 A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients
CMV
Primary: Number of Participants With Clinically Significant CMV Infection Through Week 24 Post-Transplant — 155; 78 Participants
N/A N=1,145 Integrated Management Program Advancing Community Treatment of Atrial Fibrillation
Atrial Fibrillation
Primary: Number of Participants With Cardiovascular Hospitalization and AF-related Emergency Department Visits — 118; 130 Participants
Phase 2 N=90 CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)
Acute Lymphoblastic Leukemia
Primary: Number of Patients With Response — 3; 25; 24 Participants
Phase 3 N=852 Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy
Kidney Transplantation
Primary: Number of Participants With Biopsy-proven Acute Rejection at 6-months After Randomization to Induction Therapy — 31; 68 Participants — p=<0.0001
N/A N=100 Acute Coronary Syndrome KCMC_1
Hypertension · HIV
Primary: Feasibility as Measured by the Number of Total Scheduled Intervention Sessions (CHW Counseling Sessions, Doctor's Visits, Phone Calls) Attended — 589 Scheduled sessions
N/A N=1,596 Kidney Coordinated Health Management Partnership
Chronic Kidney Diseases
Primary: Renal Failure Event Defined as Greater Than or Equal to 40% Decline in Estimated Glomerular Filtration Rate (eGFR) or Occurrence of End Stage Renal Disease (ESRD) — 9.7…
Phase 4 N=140 Intubation of Patients With an Unstable Cervical Spine Using the CMAC Device
Laminectomy
Primary: Intubation Time (Seconds) — 35; 59 Seconds
N/A N=34 DMID 21-0041; Influenza CVD 59000
Influenza
Primary: Viral Confirmation — 6; 0 Participants
N/A N=773 CAMCI: Advancing the Use of Computerized Screening in Healthcare
Cognitive Dysfunction · Cognitive Impairment · Cognitive Decline
Primary: Agreement Analysis (Agreement to Reference Standard) - Test Group — 76; 18; 2; 8 Participants
N/A N=466 Mobile Critical Care Recovery Program for Acute Respiratory Failure Survivors
Acute Respiratory Failure · Post-Intensive Care Syndrome
Primary: Self Reported Quality of Life PCS: Physical Component Score at 1 Year — 36.22; 35.29 score on a scale
Phase 3 N=153 Real World CCH Study in Adult Females With Cellulite
Edematous Fibrosclerotic Panniculopathy (EFP) · Cellulite
Primary: The Proportion of Participants With Improved (+1 or Better) Score on I-GAIS for Either Posterolateral Thigh — 58 Participants
Phase 4 N=2,199 A Chronic Care Model Based Quality Improvement (QI) Program to Improve the Care of Patients With Chronic Kidney Disease (CKD)
Chronic Kidney Disease
Primary: Systolic Blood Pressure (SBP) — 135.1; 134.4 mmHg — p=0.57
N/A N=1,112 Hybrid Collaborative Care Randomized Program Evaluation
Mental Health Disorders
Primary: Veterans RAND-12 Mental Component Score (VR-12 MCS) — 36.82; 36.24; 37.25 score on a scale — p=<0.01
N/A N=80 The Second-Generation MCCG for Upper Gastrointestinal Tract.
Capsule Endoscopy
Primary: Circumferential Visualization of the Z-line — 0; 5; 5; 7 Participants
Phase 3 N=416 PCM Cervical Disc System
Radiculopathy · Myelopathy
Primary: Individual Patient Overall Success — 142; 98 participants
N/A N=301 Development and Evaluation of an Electronic Health Record-based Medication Complete Communication (EMC2) Strategy
Medication Adherence
Primary: Medication Specific Knowledge — 63.82; 62.80 score (0-100)
Phase 2 N=167 ACT34-CMI -- Adult Autologous CD34+ Cells
Myocardial Ischemia
Primary: Number of Angina Episodes Per Week at 6 and 12 Months — 6.8; 8.3; 10.9; 6.3 angina episodes/week — p=0.020
N/A N=641 Acute Coronary Syndrome KCMC
Acute Coronary Syndrome
Primary: Acceptability as Measured by the Acceptability of Intervention Measure (AIM) — 4.82 score on a scale
Phase 4 N=615 Screening Contrast-Enhanced Mammography as an Alternative to MRI
Breast Cancer
Primary: Cancer Detection Rate (CDR) Per 1,000 Screenings — 8.3; 18.3 CDR per 1,000 screenings
N/A N=81 Cellentra Viable Cell Bone Matrix (VCBM) Anterior Cervical Discectomy and Fusion Outcomes Study (VCBM/MaxAn)
Cervical Disc Degenerative Disorder
Primary: Change in NDI From Baseline — 52.1; 28.5; 24.0 score on a scale
N/A N=30 Chaplain-Delivered Compassion Meditation to Improve Quality of Life in Patients Receiving a Stem Cell Transplant
Lymphoma · Plasma Cell Myeloma
Primary: Fidelity to Intervention Delivery — 19.9 score on a scale
Phase 2 N=239 Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients
Cytomegalovirus Infection
Primary: Number of Participants With Clinically Significant CMV Infection — 13; 4; 6; 4 Participants
N/A N=1,400 Integrated Care (IC) Models for Patient-Centered Outcomes
Diabetes · Asthma · Chronic Obstructive Pulmonary Disease
Primary: Patient Activation — 61.87; 63.73; 63.82; 63.15 score on a scale — p=0.0211
N/A N=16 Community Central Line Infection Prevention Trial
Infection
Primary: Total Number of Central Line Associated Blood Stream Infections (CLABSI) — 113; 84; 123; 109 infections
N/A N=16,264 Child Health Improvement Through Computer Automation of Constipation Management in Primary Care
Constipation · Encopresis
Primary: Number of Patients With Persistent Constipation Within 6 Months — 325; 224 participants with persistent symptoms
Phase 1 N=32 Effects Multimodal Mind and Body Approach for MCI
Mild Cognitive Impairment
Primary: Retention — 11; 15 Participants